Diana Hernandez | Director of Immune and Advanced Therapies
Anthony Nolan

Diana Hernandez, Director of Immune and Advanced Therapies, Anthony Nolan

Dr. Diana Hernandez is a stem cell biologist with more than 30 years’ experience in medical research and at least 12 years in the cell therapy field both in academia and industry. After several years in basic academic research at Imperial College and UCL, she has led several collaborative projects between academia and biotech. She currently leads a research team at Anthony Nolan, a charity established in 1974 as the first bone marrow register in the world. Her research focuses in improving the outcomes of patients undergoing bone marrow transplants by understanding the graft, and creating cell therapy products to treat relapse and GvHD.  Diana is also the Vice-Chair of the Cell and Gene Therapy Advisory committee of the UK’s Bioindustries Association (BIA).  Anthony Nolan administers the aligned UK bone marrow register, carries out research into stem cell transplant, has a series of programmes to help patients needing and undergoing stem cell transplantation and supports the cell and gene therapy industry by providing materials and services to advanced therapy developers. 

Appearances:



Day 1: 17th March 2026 @ 16:05

Chair's Remarks: Diana Hernandez, Director of Immune and Advanced Therapies, Anthony Nolan

Day 2: 18th March 2026 @ 13:35

Panel Discussion: Autologous vs. Allogeneic Approaches

Day 2: 18th March 2026 @ 14:15

CRISPR modification of NK cells

last published: 15/Sep/25 15:35 GMT

back to speakers


Get Involved with Advanced Therapies Congress

 

To sponsor or exhibit

Ashlea Foster
ashlea.foster@terrapinn.com
+44 208 164 3032

 

To speak

Chris Shanks
Chris.Shanks@terrapinn.com
+44 207 092 1150